Results 291 to 300 of about 337,127 (342)

Phase I trial of locoregional administration of autologous tumor-infiltrating lymphocytes in patients with uveal melanoma and liver metastases (the HAITILS trial). [PDF]

J Immunother Cancer
Nelson A, Riise R, Alsén S, Wong A, Carlson P, Edman S, Holgersson J, Olofsson Bagge R, Johansson I, Sadik M, Edenbrandt L, Nilsson LM, Nilsson JA, Ny L.   +13 more
europepmc   +1 more source

Correction: Lymphocyte activating gene 3 protein expression in nasopharyngeal carcinoma is correlated with programmed cell death-1 and programmed cell death ligand-1, tumor-infiltrating lymphocytes. [PDF]

Cancer Cell Int
Luo F, Cao J, Lu F, Zeng K, Ma W, Huang Y, Zhang L, Zhao H.   +7 more
europepmc   +1 more source

Title: AI-based quantification of tumor-infiltrating lymphocytes with integrative transcriptomics in ovarian clear cell carcinoma: JGOG3025-TR1/A1 study. [PDF]

Cancer Immunol Immunother
Hamada K, Hamanishi J, Ueda A, Takamatsu S, Yoshihara K, Nagasawa T, Seki T, Kikuchi A, Fujimoto E, Taki M, Yamanoi K, Murakami R, Kumada K, Oda K, Shimada M, Okamoto A, Mandai M, Matsumura N.   +17 more
europepmc   +1 more source

Clinical characteristics and prognostic impact of HER2-ultralow breast cancer and tumor-infiltrating lymphocytes (TILs). [PDF]

BMC Cancer
Takada K, Kashiwagi S, Nishikawa M, Kochi A, Watanabe C, Kinoshita H, Ogisawa K, Shibutani M, Morisaki T.   +8 more
europepmc   +1 more source

Tumor infiltrating lymphocytes in ovarian cancer [PDF]

Cancer Biology and Therapy, 2015
Several improvements in ovarian cancer treatment have been achieved in recent years, both in surgery and in combination chemotherapy with targeting. However, ovarian tumors remain the women's cancers with highest mortality rates.
Daniel J Powell
exaly   +9 more sources

Some of the next articles are maybe not open access.

Related searches:

Tumor-infiltrating lymphocytes: A new hope.

Cancer Cell
Tumor-infiltrating lymphocytes (TILs) can be massively expanded from resected tumors and used as a cellular treatment for advanced malignancies. TILs require a preparative non-myeloablative chemotherapy followed by an abbreviated course of interleukin-2.
A. Sarnaik, Patrick Hwu, James J. Mulé, S. Pilon-Thomas   +3 more
semanticscholar   +3 more sources

The association between CD8+ tumor-infiltrating lymphocytes and the clinical outcome of cancer immunotherapy: A systematic review and meta-analysis

EClinicalMedicine, 2021
Background The responses of cancer patients to immune checkpoint inhibitors (ICIs) vary in success. CD8+ tumor infiltrating lymphocytes (TILs) play a key role in killing tumor cells.
Xiuyu Cai, Zhanhong Xie, Ran Zhong
exaly   +2 more sources

Tumor-infiltrating lymphocytes: Warriors fight against tumors powerfully

Biomedicine and Pharmacotherapy, 2020
Tumor-infiltrating lymphocytes (TILs) are infiltrating lymphocytes in tumor tissues. After isolation, screening and amplification in vitro, they will be implanted into patients and play a specific killing effect on tumors.
Xiao Zhu, Liao Cui, Xiaosong Li
exaly   +2 more sources

Tumor-Infiltrating Lymphocytes

The Cancer Journal, 2015
Adoptive cell therapy (ACT) with tumor-infiltrating lymphocytes (TILs) in combination with lymphodepletion and high-dose interleukin 2 has shown reproducible objective response rates of approximately 50% in patients with highly advanced, refractory metastatic melanoma.
Michal J, Besser, Ronnie, Shapira-Frommer, Jacob, Schachter   +2 more
openaire   +3 more sources

Prognostic value of tumor-infiltrating lymphocytes in melanoma: a systematic review and meta-analysis

OncoImmunology, 2019
Tumor-infiltrating lymphocytes (TILs) are associated with prognosis in various tumors. However, it remains controversial whether the presence of TILs is related to an improved prognosis in melanoma.
Qiaofen Fu, Chunlei Ge, Ruilei Li
exaly   +2 more sources